Exec Chat: How Edwards Lifesciences Deploys AI, Remote Monitoring To Help Doctors Make Life-Critical Decisions
Executive Summary
Edwards Lifesciences’ head of critical care expects that “smart recovery” AI-driven products will grow the fastest in its critical care unit, which is expected to reach $800m in total revenues for 2021.
You may also be interested in...
Edwards Plans To Boost Growth By Spinning Off Critical Care Unit In 2024
The critical care business is developing smart-recovery products integrated into Edwards’ HemoSphere monitoring platform. The company expects the tax-free transaction will help the new company advance patient monitoring technology and let Edwards focus on its structural heart technologies.
FDA Continues To Down-Classify Digital Health Apps With New Cardio App Rule
US regulators have officially down-classified adjunctive predictive cardiovascular indicator software to class II as part of a trend to make it easier for sponsors to apply for premarket applications.
Edwards Keeps TAVR Going During COVID-19 Surge
Fourth-quarter sales of Edwards Sapien transcatheter aortic valve systems grew 2% year-over-year overall, despite the intense challenges created by COVID-19.